Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study
Nutrition, Metabolism and Cardiovascular Diseases · 2023
DOI: 10.1016/j.numecd.2023.02.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2023. Verfasst von Yukino Katakura und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. Hauptthemen laut MEDLINE: Hypertriglyceridemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kawasaki Medical School.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
- Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. Electronic address: masashi-s@med.kawasaki-m.ac.jp.
Förderung
- Kawasaki Medical School
Zitieren
APA
Katakura, Y., Shimoda, M., Ohnishi, M., Kusano, T., Dan, K., Isobe, H., Wamata, R., Iwamoto, Y., Fushimi, Y., Sanada, J., Obata, A., Kimura, T., Tatsumi, F., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2023). Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2023.02.011
Vancouver
Katakura Y, Shimoda M, Ohnishi M, Kusano T, Dan K, Isobe H, et al. Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study. Nutrition, Metabolism and Cardiovascular Diseases. 2023. doi:10.1016/j.numecd.2023.02.011
BibTeX
@article{Katakura2023,
author = {Katakura, Yukino and Shimoda, Masashi and Ohnishi, Mana and Kusano, Takashi and Dan, Kazunori and Isobe, Hayato and Wamata, Ryo and Iwamoto, Yuichiro and Fushimi, Yoshiro and Sanada, Junpei and Obata, Atsushi and Kimura, Tomohiko and Tatsumi, Fuminori and Nakanishi, Shuhei and Mune, Tomoatsu and Kaku, Kohei and Kaneto, Hideaki},
title = {Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2023},
doi = {10.1016/j.numecd.2023.02.011}
}
EUVIMED